Introduction to Advanced Wound Management Solutions

The management of persistent microbial infections and chronic inflammation in cutaneous wounds remains a significant clinical challenge. Prolonged application and high doses of conventional antimicrobial agents frequently lead to the emergence of multi-drug-resistant bacterial strains. Consequently, this therapeutic bottleneck severely impedes tissue repair, prolongs hospital stays, and increases healthcare costs. To overcome these limitations, clinical researchers are actively investigating innovative therapeutic modalities that operate independently of traditional pharmaceutical antibiotics. Innovative biomaterials offer a promising frontier by combining direct antimicrobial mechanisms with regenerative support. Among these technologies, light-activated therapies have gained substantial traction in modern surgical and dermatological care. Specifically, chitosan hydrogel photodynamic therapy has emerged as a novel strategy to eliminate resistant pathogens without inducing antimicrobial resistance. By utilizing biocompatible biopolymer matrices integrated with specialized photosensitizing agents, these therapeutic platforms generate localized cytotoxic reactive oxygen species upon light excitation. However, the microenvironment of infected, chronic wounds is typically hypoxic, which severely restricts the overall efficacy of oxygen-dependent light treatments. To address this oxygen deficit, recent advanced bioengineering strategies aim to incorporate self-oxygen-supplying nanocomposites directly into the hydrogel architecture to ensure sustained therapeutic action.

Mechanistic Breakdown of the TAPP/MnO@CS-GA Nanosystem

The novel degradable hybrid nanohydrogel system, designated as TAPP/MnO@CS-GA, is engineered by incorporating two active functional components within a glutaraldehyde-crosslinked chitosan hydrogel backbone. The primary photosensitizing component is 5,10,15,20-tetrakis (4-aminophenyl)-21H,23H-porphine, abbreviated as TAPP, which provides robust photodynamic properties. The second key functional element consists of manganese oxide nanoparticles, which exhibit dual intrinsic enzyme-like catalytic activities, specifically superoxide dismutase and catalase mimicry. When introduced into the wound bed, the chitosan matrix provides a biocompatible, moist scaffold that supports cellular migration and structural integrity. Glutaraldehyde crosslinking ensures optimal mechanical stability, controlled degradation kinetics, and sustained release of the embedded nanocomposites. The integration of manganese oxide directly targets the unfavorable biochemical microenvironment of infected tissue. Pathological wound exudates routinely contain high concentrations of cytotoxic superoxide anion radicals and hydrogen peroxide due to continuous oxidative stress and persistent inflammatory cell recruitment. The enzyme-mimicking manganese oxide component rapidly catalyzes the dismutation and decomposition of these harmful endogenous reactive species, efficiently converting them into molecular oxygen directly within the localized tissue matrix.

Chitosan Hydrogel Photodynamic Therapy and Oxygen Generation

A primary failure point of traditional light-based treatments in deep or chronic wound beds is the rapid depletion of local tissue oxygen. Modern chitosan hydrogel photodynamic therapy overcomes this physiological barrier through its self-oxygenation cascade. Under targeted laser irradiation, the embedded TAPP photosensitizer absorbs light energy and transfers it to ground-state oxygen molecules, generating highly reactive singlet oxygen capable of destroying bacterial membranes and cellular structures. Simultaneously, the manganese oxide nanoparticles continuously convert excessive endogenous superoxide anions and hydrogen peroxide into continuous streams of dissolved molecular oxygen. This enzymatic activity supplies an abundant, uninterrupted substrate specifically required for TAPP-mediated photodynamic reactions. As a result, the localized concentration of singlet oxygen is significantly augmented compared to conventional photosensitizing systems operating under hypoxic constraints. This self-sustaining feedback loop dramatically elevates the overall photodynamic efficacy, ensuring thorough microbial eradication even in deep tissue layers where atmospheric oxygen diffusion is severely restricted. Furthermore, because this bacterial clearance relies on direct oxidative damage rather than pharmacological pathways, pathogens cannot easily develop evolutionary resistance mechanism against the treatment.

Mitigating Oxidative Stress and Promoting Angiogenesis

Beyond immediate bactericidal actions, the sustained clinical utility of therapeutic hydrogels depends on their ability to modulate post-treatment inflammation and promote tissue repair. Following light irradiation, the catalytic functions of the TAPP/MnO@CS-GA hydrogel continue to actively benefit the underlying wound bed. The persistent superoxide dismutase and catalase activities of the manganese oxide nanoparticles continuously clear accumulating superoxide radicals and hydrogen peroxide from the extracellular matrix. By scavenging these destructive reactive oxygen species, the hydrogel effectively mitigates persistent local oxidative stress, protecting surrounding healthy keratinocytes, fibroblasts, and endothelial cells from secondary collateral damage. Furthermore, the continuous enzymatic generation of oxygen alleviates chronic tissue hypoxia, which is a key driver of non-healing wound states. Resolving local hypoxia serves as a direct stimulus for endothelial cell proliferation, migration, and capillary tube formation. Consequently, the hydrogel accelerates robust angiogenesis, restoring microvascular perfusion and facilitating the continuous supply of essential nutrients and systemic immune cells necessary for definitive tissue reconstruction and re-epithelialization.

Clinical Implications for Antimicrobial Stewardship

The clinical translation of self-oxygenating photoactive hydrogels represents a significant advancement in non-antibiotic infection control strategies. Microbial resistance to broad-spectrum systemic and topical antibiotics presents an escalating threat to global public health, particularly in burn care, diabetic ulcer management, and postoperative surgical wound complications. By combining robust physical antimicrobial mechanisms with active anti-inflammatory and pro-angiogenic actions, the TAPP/MnO@CS-GA hydrogel addresses multiple aspects of chronic wound pathogenesis simultaneously. Experimental results confirm that this dual-action platform rapidly clears bacterial loads while converting a hostile, chronically inflamed microenvironment into a pro-regenerative niche. For clinicians, adopting non-antibiotic interventions reduces reliance on traditional prescription antimicrobials, directly supporting institutional antimicrobial stewardship objectives. Additionally, the biodegradable nature of the chitosan backbone ensures that the material safely degrades as healing progresses, minimizing the need for painful dressing removals or invasive surgical debridement. As clinical trials further validate these biomaterials, self-supplying photodynamic hydrogels are poised to become standard adjuncts in advanced wound care regimens.

Frequently Asked Questions

How does the self-oxygenating chitosan hydrogel overcome wound hypoxia during photodynamic therapy?

The hydrogel incorporates manganese oxide nanoparticles possessing superoxide dismutase and catalase-like activities. These nanoparticles actively convert endogenous harmful reactive oxygen species, such as hydrogen peroxide and superoxide radicals, into molecular oxygen. This self-generated oxygen acts as a continuous substrate for the photosensitizer TAPP during laser irradiation, generating abundant singlet oxygen to kill bacteria efficiently despite baseline tissue hypoxia.

Why is this non-antibiotic hydrogel therapeutic approach beneficial for chronic infected wounds?

Chronic wounds frequently harbour antibiotic-resistant bacteria that resist standard pharmacological treatments. By using photodynamic therapy combined with ROS scavenging, the hydrogel destroys bacterial cell structures through broad oxidative stress without inducing drug resistance. Simultaneously, it reduces excessive tissue inflammation, alleviates hypoxia, and promotes microvascular angiogenesis, creating optimal biological conditions for complete wound closure and rapid tissue repair.

What role does the chitosan polymer matrix play in wound healing applications?

Chitosan provides a biocompatible, biodegradable, and hydrophilic scaffold that maintains a moist wound environment essential for cellular migration. Crosslinked with glutaraldehyde, it steadily releases active nanocomposites while maintaining structural integrity. As the wound heals, the chitosan matrix safely breaks down, preventing tissue trauma during dressing changes and supporting cellular infiltration, tissue regeneration, and structural re-epithelialization.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Healthcare professionals should rely on their clinical judgment and refer to the latest local and national guidelines for clinical practice.

References

1. Xu N et al. Porphyrin‑manganese trioxide-doped chitosan hydrogel with self‑oxygen supply enhancing photodynamic therapy effect for antibacterial and anti-inflammatory of infected wounds. Int J Biol Macromol. 2026 Aug 10. doi: undefined. PMID: 42574815.
2. Chitosan-based hydrogel incorporated with polydopamine and protoporphyrin for photothermal-oxidation sterilization of bacteria-infected wound therapy. J Colloid Interface Sci. 2025 Jan 15. PMID: 39277956.